Correlation Between Centessa Pharmaceuticals and PAO NOVATEK

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and PAO NOVATEK at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and PAO NOVATEK into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and PAO NOVATEK, you can compare the effects of market volatilities on Centessa Pharmaceuticals and PAO NOVATEK and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of PAO NOVATEK. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and PAO NOVATEK.

Diversification Opportunities for Centessa Pharmaceuticals and PAO NOVATEK

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Centessa and PAO is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and PAO NOVATEK in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PAO NOVATEK and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with PAO NOVATEK. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PAO NOVATEK has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and PAO NOVATEK go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and PAO NOVATEK

If you would invest  1,646  in Centessa Pharmaceuticals PLC on September 15, 2024 and sell it today you would earn a total of  11.00  from holding Centessa Pharmaceuticals PLC or generate 0.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.56%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  PAO NOVATEK

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
PAO NOVATEK 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PAO NOVATEK has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable forward-looking signals, PAO NOVATEK is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Centessa Pharmaceuticals and PAO NOVATEK Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and PAO NOVATEK

The main advantage of trading using opposite Centessa Pharmaceuticals and PAO NOVATEK positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, PAO NOVATEK can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PAO NOVATEK will offset losses from the drop in PAO NOVATEK's long position.
The idea behind Centessa Pharmaceuticals PLC and PAO NOVATEK pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments